Susan Berson and Brent Henry Recognized as Health Care Trailblazers by the National Law Journal
Filter by:
What It Actually Takes To Bring A Relative To The U.S.
March 5, 2018
  This piece focuses on the issue of family migration – a hot topic in the ongoing immigration debate. Member and Founder of the firm’s Immigration Practice Susan Cohen is among those sources quoted providing commentary.
                                      Movers & Shakers
March 2, 2018
  Expanding the firm’s technology capabilities, Mintz welcomed new Members Dinesh K. Melwani and William S. Perkins to the firm on February 27.  The news was carried in The Deal’s Movers and Shakers column.  Will and Dinesh work with emerging technology and life sciences companies.
                                      Mintz Adds Morgan Lewis Tech Duo In Boston
March 1, 2018
  Law 360 highlighted the arrival of Mintz Members Dinesh K. Melwani and William S. Perkins who joined the firm February 27th.  Will and Dinesh have represented technology, life sciences and start-up companies in financings, M&A transactions and general corporate matters.
                                      BBA Council Supports Streamlined Post-Conviction Relief for Human Trafficking Survivors
March 1, 2018
  Mintz attorneys Lavinia Weizel and Alec Zadek were featured in the Boston Bar Association’s newsletter regarding the Human Trafficking Subcommittee. Alec has served as co-chair since the subcommittee was launched in 2014. Lavinia Weizel has joined the subcommittee. 
                                      Mintz’s Kurt Steinkrauss to Receive Boston Estate Planning Council’s Excellence Award
February 28, 2018
  Mintz is pleased to announce Member Kurt Steinkrauss has been named the recipient of the 2018 Boston Estate Planning Council (BEPC) Excellence Award. The BEPC Excellence Award is given in recognition of outstanding contributions to the estate planning profession.
                                      Mintz Advises Viela Bio in Spin Out of Medimmune
February 28, 2018
  Viela Bio announced it has incorporated as an independent inflammation- and autoimmunity-focused biotechnology company after spinning out six molecules from MedImmune, the global biologics research and development arm of AstraZeneca. 
                                      